Troglitazone monotherapy improves glycemic control in patients with type 2 diabetes mellitus: a randomized, controlled study. The Troglitazone Study Group. - Fonseca,V.A.; Valiquett,T.R.; Huang,S.M.; Ghazzi,M.N.; Whitcomb,R.W. (J Clin Endocrinol Metab, 1998)